These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Editor's introduction: psychedelic resurgence--research and therapeutic uses, past and present. Chambers T J Psychoactive Drugs; 2014; 46(1):1-2. PubMed ID: 24830179 [No Abstract] [Full Text] [Related]
5. Psychedelics in Psychiatry-Keeping the Renaissance From Going Off the Rails. Yaden DB; Yaden ME; Griffiths RR JAMA Psychiatry; 2021 May; 78(5):469-470. PubMed ID: 33263720 [No Abstract] [Full Text] [Related]
6. Psychedelic Psychiatry: Preparing for Novel Treatments Involving Altered States of Consciousness. Holoyda B Psychiatr Serv; 2020 Dec; 71(12):1297-1299. PubMed ID: 33050796 [TBL] [Abstract][Full Text] [Related]
7. From Hofmann to the Haight Ashbury, and into the future: the past and potential of lysergic acid diethlyamide. Smith DE; Raswyck GE; Davidson LD J Psychoactive Drugs; 2014; 46(1):3-10. PubMed ID: 24830180 [TBL] [Abstract][Full Text] [Related]
8. Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer. Barnett BS; Greer GR J Acad Consult Liaison Psychiatry; 2021; 62(4):460-471. PubMed ID: 34210406 [TBL] [Abstract][Full Text] [Related]
9. Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry. Barber GS; Dike CC Psychiatr Serv; 2023 Aug; 74(8):838-846. PubMed ID: 36987705 [TBL] [Abstract][Full Text] [Related]
11. Can psychedelics have a role in psychiatry once again? Sessa B Br J Psychiatry; 2005 Jun; 186():457-8. PubMed ID: 15928353 [No Abstract] [Full Text] [Related]
12. The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future. Carhart-Harris RL; Goodwin GM Neuropsychopharmacology; 2017 Oct; 42(11):2105-2113. PubMed ID: 28443617 [TBL] [Abstract][Full Text] [Related]
13. Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humans. Heal DJ; Gosden J; Smith SL Neuropharmacology; 2018 Nov; 142():89-115. PubMed ID: 29427652 [TBL] [Abstract][Full Text] [Related]
14. Psychedelic-assisted therapies: The past, and the need to move forward responsibly. Gardner J; Carter A; O'Brien K; Seear K Int J Drug Policy; 2019 Aug; 70():94-98. PubMed ID: 31136924 [TBL] [Abstract][Full Text] [Related]
15. Psychiatry might need some psychedelic therapy. Johnson MW Int Rev Psychiatry; 2018 Aug; 30(4):285-290. PubMed ID: 31282826 [No Abstract] [Full Text] [Related]
16. Psychedelics and Dying Care: A Historical Look at the Relationship between Psychedelics and Palliative Care. Dyck E J Psychoactive Drugs; 2019; 51(2):102-107. PubMed ID: 30821651 [TBL] [Abstract][Full Text] [Related]
17. Contextual Parameters Associated with Positive and Negative Mental Health in Recreational Psychedelic Users. St Arnaud KO; Sharpe D J Psychoactive Drugs; 2023; 55(1):30-39. PubMed ID: 35156542 [TBL] [Abstract][Full Text] [Related]
18. Second thoughts on psychedelic drugs. Novak SJ Endeavour; 1998; 22(1):21-3. PubMed ID: 9588116 [TBL] [Abstract][Full Text] [Related]
19. Is there a case for MDMA-assisted psychotherapy in the UK? Sessa B J Psychopharmacol; 2007 Mar; 21(2):220-4. PubMed ID: 17329304 [TBL] [Abstract][Full Text] [Related]
20. Psychedelics and psychotherapy in Canada: Humphry Osmond and Aldous Huxley. Dyck E; Farrell P Hist Psychol; 2018 Aug; 21(3):240-253. PubMed ID: 30138029 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]